跳至主要内容
临床试验/NCT02050269
NCT02050269已完成3 期

Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study

University Hospital, Tours3 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
100
试验地点
3
主要终点
Plasma clearance of iohexol

研究概览

简要总结

The objective of this study is to assess the feasibility of estimating the clearance of iohexol as an indirect measure of glomerular filtration rate in patients with unstable renal function in the intensive care unit through analysis of rich iohexol plasma kinetics.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Patient admitted to intensive care for less than 12 hours
  • Acute circulatory failure
  • Patient carrying an arterial catheter
  • Informed consent obtained
  • Affiliated to social security system

排除标准

  • Administration of iohexol the week before intensive care admission
  • Administration of iohexol expected within 24 hours of study entry
  • Known history of cutaneous immediate or delayed allergic reaction to the injection of the product
  • Indication for albumin transfusion within 24 hours of potential inclusion in the study
  • Pregnancy or breastfeeding in progress
  • Patient under guardianship or judicial protection known at the time of inclusion
  • Withdrawal of consent
  • Administration of iohexol outside the study within 24 hours after administration of iohexol in the context of the study
  • Administration of intravenous albumin in the 24 hours following administration of iohexol in the context of the study

研究组 & 干预措施

Iohexol

Experimental

injection of 5 ml of iohexol

干预措施: Iohexol (Drug)

结局指标

主要结局

Plasma clearance of iohexol

时间窗: 24 hours

次要结局

  • Link between plasma iohexol clearance and kindney injury markers(24 hours)
  • Comparaison of plasma iohexol clearance measured with 3 and 6 vs. 9 kinetic points(24 hours)
  • Plasma clearance of iohexol in patients developping or not acute kidney injury(7 days)
  • Link between plasma iohexol clearance and urinary metabolomic markers(24 hours)
  • Link between injury and/or functional kidney dammage and subsequent acute kidney injury(7 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验